FDA Issues Warning About Rare but Serious Liver Injury With the Use of Fezolinetant (VEOZAH) for Hot Flashes Due to Menopause
View all alerts
Worst Pills, Best Pills

An expert, independent second opinion on more than 1,800 prescription drugs, over-the-counter medications, and supplements

donepezil (ARICEPT, ARICEPT 23)


DRUG AND DIETARY SUPPLEMENT PROFILES

A comprehensive review of the safety and effectiveness of this drug. If the drug is not a Do Not Use product, information on adverse effects, drug interactions and how to use the medication are included.
Search results below include Drug and Dietary Supplement Profiles where your selected drug is a secondary subject of discussion.

galantamine (RAZADYNE, RAZADYNE ER); rivastigmine (EXELON)
  • We list these drugs as Do Not Use drugs primarily because they are minimally effective.

WORST PILLS, BEST PILLS NEWSLETTER ARTICLES

Search results below include Worst Pills, Best Pills Newsletter Articles where your selected drug is a secondary subject of discussion.

Vitamin E Does Not Prevent Declines in Memory and Cognitive Function
October 2017
Dietary supplement makers often tout vitamin E products for a variety of purported health benefits, including the promotion of brain health. Find out why vitamin E supplements are unlikely to prevent cognitive decline and may cause serious harm if taken in doses exceeding the recommended dietary allowance.
Memantine: Still a Poor Choice for Alzheimer’s Disease
May 2016
Memantine (NAMENDA) recently has been one of the drugs for Alzheimer’s disease most heavily promoted through direct-to-consumer advertising. Learn why we have designated memantine as Do Not Use.
Troubling New Drug Approvals in 2012
March 2013
Find out which drugs approved in 2012 have risks greatly exceeding their benefits or no meaningful benefits. If you are using any of the DO NOT USE drugs reviewed in the article, talk to your doctor before stopping their use.
Drug Mix-Ups
June 2011
This article lists 355 drugs with names that are often confused with similar-sounding drug names. Find out what you can do to prevent getting the wrong drug.
Deaths Attributed To The Alzheimer’s Disease Drug Galantamine (REMINYL)
March 2005
There is no evidence that this drug leads to substantial functional improvement or prevents the progression of the disease, and new evidence indicates that it may increase the risk of death.
Oxybutynin Patches (OXYTROL): A Grossly Overpriced Product For Overactive Bladder
July 2003
You should check the list of drugs that can cause loss of bladder control before starting drug treatment for this condition. You may be able to change from a drug that causes loss of bladder control to a drug that does not or alter the dose. This may be enough to solve the problem.
New Safety Warning For the Alzheimer’s Disease Drug Rivastigmine (EXELON)
March 2001
In the January 2001 issue of Worst Pills, Best Pills News we recommended that the new Alzheimer’s disease drug rivastigmine (EXELON), the third such drug on the market, should not be used for at least five years. This would be April 2005.
Do Not Use Before April 2005 Rivastigmine (EXELON)—A Third Drug For Alzheimer’s Disease
January 2001
The Food and Drug Administration (FDA) approved a third drug, rivastigmine (EXELON), in April 2000 for the treatment of mild to moderate dementia of the Alzheimer’s type. Rivastigmine was preceded by tacrine (COGNEX) approved in September 1993 and donepezil (ARICEPT) cleared by the FDA in November 1996.

Show primary search results for donepezil (ARICEPT, ARICEPT 23)

Disclaimer

The information on this website is not intended to substitute for professional medical advice, diagnosis, or treatment. Consult your doctor before changing or discontinuing any medication.